NDC 0378-5575-01 - Modafinil

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0378-5575
Requested NDC
0378-5575-01
Package NDCs from labels
0378-5575-93, 0378-5575-05, 0378-5575-01
Manufacturer
Mylan Institutional Inc.
Effective date
2019-11-07
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Modafinil - Mylan Institutional Inc.Mylan Institutional Inc.2019-11-07HUMAN PRESCRIPTION DRUG LABEL
Modafinil - Preferred Pharmaceuticals Inc.Preferred Pharmaceuticals Inc.2019-10-31HUMAN PRESCRIPTION DRUG LABEL
Modafinil - Mylan Pharmaceuticals Inc.Mylan Pharmaceuticals Inc.2016-03-17HUMAN PRESCRIPTION DRUG LABEL
Modafinil - Aphena Pharma Solutions - Tennessee, LLCAphena Pharma Solutions - Tennessee, LLC2014-04-03HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2013-02-13Indexing - Billing Unit

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0378-5575-01EA - Each0378-5575c1aa9f9a-3b66-4f85-a554-b2a0ea9a339912013-02-13
0378-5575-05EA - Each0378-5575f12cf010-198e-40b0-b820-3eab9c75c67812013-02-13
0378-5575-93EA - Each0378-5575e79ed0aa-9321-4f3a-b19a-6a10905d27f012013-03-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
MODAFINILACTIVE INGREDIENTR3UK8X3U3DMODAFINIL TABLET [MYLAN PHARMACEUTICALS INC.]7
MODAFINILACTIVE MOIETYR3UK8X3U3DMODAFINIL TABLET [MYLAN PHARMACEUTICALS INC.]7
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JMODAFINIL TABLET [MYLAN PHARMACEUTICALS INC.]7
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UMODAFINIL TABLET [MYLAN PHARMACEUTICALS INC.]7
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48MODAFINIL TABLET [MYLAN PHARMACEUTICALS INC.]7
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XMODAFINIL TABLET [MYLAN PHARMACEUTICALS INC.]7
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30MODAFINIL TABLET [MYLAN PHARMACEUTICALS INC.]7
POVIDONESINACTIVE INGREDIENTFZ989GH94EMODAFINIL TABLET [MYLAN PHARMACEUTICALS INC.]7
MODAFINILACTIVE INGREDIENTR3UK8X3U3DMODAFINIL TABLET [MYLAN INSTITUTIONAL INC.]3
MODAFINILACTIVE MOIETYR3UK8X3U3DMODAFINIL TABLET [MYLAN INSTITUTIONAL INC.]3
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JMODAFINIL TABLET [MYLAN INSTITUTIONAL INC.]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UMODAFINIL TABLET [MYLAN INSTITUTIONAL INC.]3
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48MODAFINIL TABLET [MYLAN INSTITUTIONAL INC.]3
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XMODAFINIL TABLET [MYLAN INSTITUTIONAL INC.]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30MODAFINIL TABLET [MYLAN INSTITUTIONAL INC.]3
POVIDONESINACTIVE INGREDIENTFZ989GH94EMODAFINIL TABLET [MYLAN INSTITUTIONAL INC.]3
MODAFINILACTIVE INGREDIENTR3UK8X3U3DMODAFINIL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1
MODAFINILACTIVE MOIETYR3UK8X3U3DMODAFINIL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JMODAFINIL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UMODAFINIL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48MODAFINIL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XMODAFINIL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30MODAFINIL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1
POVIDONESINACTIVE INGREDIENTFZ989GH94EMODAFINIL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 7 · 121 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Equaline Advanced Relief Eye DropsDEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDEUnited Natural Foods, Inc.f7602789-179a-edfc-e053-6294a90a08442023-12-20WarningsExact identifier
unii: FZ989GH94E
Topcare Health Artificial TearsPOLYVINYL ALCOHOL, POVIDONETopco Associates LLC9c614c0e-5862-682f-e053-2a95a90abc092023-12-20WarningsExact identifier
unii: FZ989GH94E
TopCare Health Advanced Moisturizing Plus Redness ReliefDEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCLTopco Associates LLC9c6193a6-d822-1b27-e053-2995a90ab3cf2023-12-20WarningsExact identifier
unii: FZ989GH94E
HEB Advanced Eye DropsDEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDEHEB Grocery Company, LPf76281d6-3aea-349b-e053-6394a90afca22023-12-20WarningsExact identifier
unii: FZ989GH94E
Good Neighbor Pharmacy Artifical Tears Lubricant Eye DropsPOLYVINYL ALCOHOL, POVIDONEProficient Rx LP73e12596-6dd5-4cd2-83ed-992e1211b4b82023-12-01WarningsExact identifier
unii: FZ989GH94E
ModafinilMODAFINILViona Pharmaceuticals Inc15739a31-2433-49b5-90ea-b974214f73be2023-11-10Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
ModafinilMODAFINILBionpharma Inc.63604fef-0b80-40ce-8dbf-3384f1aee3952023-07-21Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
ModafinilMODAFINILProficient Rx LPd97684d7-c236-451e-99bd-b8df4bf366432023-06-01Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
ModafinilMODAFINILCIMA LABS INC.9f3b0bd2-72a3-411f-aeec-b533373f1a972023-01-31Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
ModafinilMODAFINILAphena Pharma Solutions - Tennessee, LLCa4a27496-0f5a-4ea8-b48c-72fcb323dc8f2023-01-16Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
ModafinilMODAFINILProficient Rx LPccf7836d-c131-4e7d-a339-fbf99fe7f4492023-01-01Warnings, Adverse reactionsExact identifier
unii: R3UK8X3U3D
ProvigilMODAFINILCephalon, LLCe16c26ad-7bc2-d155-3a5d-da83ad6492c82022-12-31Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
ModafinilMODAFINILAlembic Pharmaceuticals Limited5b8496fe-b647-4ce6-aeef-71245712e46f2022-06-03Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
ModafinilMODAFINILAlembic Pharmaceuticals Inc.41f9ddbd-5228-4f0c-b0aa-2056af79a21e2021-10-01Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
Melange combinationCALCAREA SULPHURICA, CALCIUM PHOSPHORICUM, KALI MURIATICUM, KALIUM PHOSPHORICUM, KALI SULPHURICUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRIUM SULFURICUM, CALCAREA FLUORICA, FERRUM PHOSPHORICUM, SILICEASeroyal USA0a071fbf-0075-4479-e054-00144ff8d46c2021-07-14WarningsExact identifier
unii: L11K75P92J
MEDULLOSSEINUM PLEXARNICA MONTANA, CALCAREA PHOSPHORICA, CALENDULA OFFICINALIS, HYPERICUM PERFORATUM, MEDULLOSSEINUM, PULSATILLA, RUTA GRAVEOLENS, SYMPHYTUM OFFICINALESeroyal USA22b7eafe-ef76-0677-e054-00144ff88e882020-10-09WarningsExact identifier
unii: L11K75P92J
60c4da65-7554-4b45-a444-120b79988be9c8101f2f-c05f-445d-a2ed-cfbff84de0702020-07-27Warnings, Adverse reactionsExact identifier
spl set id: c8101f2f-c05f-445d-a2ed-cfbff84de070
96c2ee5a-0754-7774-e053-2995a90ad6fc1f89a085-c937-4e77-9e90-fb04536cb4602019-11-07Warnings, Adverse reactionsExact identifier
spl id: 96c2ee5a-0754-7774-e053-2995a90ad6fc
spl set id: 1f89a085-c937-4e77-9e90-fb04536cb460
modafinilMODAFINILAphena Pharma Solutions - Tennessee, LLCcad4201c-133c-4a61-9d93-3c5e516954302017-12-19Warnings, Adverse reactionsExact identifier
rxcui: 205324
unii: R3UK8X3U3D
f95ebc11-320c-4520-8268-9141128b1ffef3b3097f-80b8-4410-af21-dcdea144e3c32016-03-17Warnings, Adverse reactionsExact identifier
spl set id: f3b3097f-80b8-4410-af21-dcdea144e3c3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.